Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Lawrence E. Feldman"'
Autor:
Alexandre F. Aissa, Abul B. M. M. K. Islam, Majd M. Ariss, Cammille C. Go, Alexandra E. Rader, Ryan D. Conrardy, Alexa M. Gajda, Carlota Rubio-Perez, Klara Valyi-Nagy, Mary Pasquinelli, Lawrence E. Feldman, Stefan J. Green, Nuria Lopez-Bigas, Maxim V. Frolov, Elizaveta V. Benevolenskaya
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-25 (2021)
It has been proposed that resistance to targeted therapies in non-small cell lung carcinoma (NSCLC) is due to a nonhomogeneous cell population. Here the authors analyse preclinical NSCLC models using single-cell RNA-seq and identify drug tolerant cel
Externí odkaz:
https://doaj.org/article/07bdc3f7e13d4e018edb5f1887d9c903
Autor:
Mary M. Pasquinelli, DNP, Martin C. Tammemägi, PhD, Kevin L. Kovitz, MD, Marianne L. Durham, DNP, Zanë Deliu, MS, Kayleigh Rygalski, BS, Li Liu, PhD, Matthew Koshy, MD, Patricia Finn, MD, Lawrence E. Feldman, MD
Publikováno v:
JTO Clinical and Research Reports, Vol 2, Iss 3, Pp 100137- (2021)
Introduction: Eligibility criteria for lung cancer screening based solely on age and smoking history are less sensitive than validated risk prediction models. The U.S. Preventive Services Task Force (USPSTF) has proposed new guidelines to improve the
Externí odkaz:
https://doaj.org/article/413fd9ff97a04e079d64e45899f40512
Autor:
Jyoti Malhotra, Alberto Chiappori, Salma K Jabbour, Chunxia Chen, Naomi Fujioka, Nasser H Hanna, Lawrence E Feldman, Malini Patel, Dirk Moore
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/edb5bb1d7a984bf9ac497fa785f2f4b7
Autor:
Gayathri Nagaraj, Shaveta Vinayak, Ali Raza Khaki, Tianyi Sun, Nicole M Kuderer, David M Aboulafia, Jared D Acoba, Joy Awosika, Ziad Bakouny, Nicole B Balmaceda, Ting Bao, Babar Bashir, Stephanie Berg, Mehmet A Bilen, Poorva Bindal, Sibel Blau, Brianne E Bodin, Hala T Borno, Cecilia Castellano, Horyun Choi, John Deeken, Aakash Desai, Natasha Edwin, Lawrence E Feldman, Daniel B Flora, Christopher R Friese, Matthew D Galsky, Cyndi J Gonzalez, Petros Grivas, Shilpa Gupta, Marcy Haynam, Hannah Heilman, Dawn L Hershman, Clara Hwang, Chinmay Jani, Sachin R Jhawar, Monika Joshi, Virginia Kaklamani, Elizabeth J Klein, Natalie Knox, Vadim S Koshkin, Amit A Kulkarni, Daniel H Kwon, Chris Labaki, Philip E Lammers, Kate I Lathrop, Mark A Lewis, Xuanyi Li, Gilbert de Lima Lopes, Gary H Lyman, Della F Makower, Abdul-Hai Mansoor, Merry-Jennifer Markham, Sandeep H Mashru, Rana R McKay, Ian Messing, Vasil Mico, Rajani Nadkarni, Swathi Namburi, Ryan H Nguyen, Taylor Kristian Nonato, Tracey Lynn O'Connor, Orestis A Panagiotou, Kyu Park, Jaymin M Patel, Kanishka GopikaBimal Patel, Jeffrey Peppercorn, Hyma Polimera, Matthew Puc, Yuan James Rao, Pedram Razavi, Sonya A Reid, Jonathan W Riess, Donna R Rivera, Mark Robson, Suzanne J Rose, Atlantis D Russ, Lidia Schapira, Pankil K Shah, M Kelly Shanahan, Lauren C Shapiro, Melissa Smits, Daniel G Stover, Mitrianna Streckfuss, Lisa Tachiki, Michael A Thompson, Sara M Tolaney, Lisa B Weissmann, Grace Wilson, Michael T Wotman, Elizabeth M Wulff-Burchfield, Sanjay Mishra, Benjamin French, Jeremy L Warner, Maryam B Lustberg, Melissa K Accordino, Dimpy P Shah, On behalf of the COVID-19 and Cancer Consortium
Publikováno v:
eLife, Vol 12 (2023)
Background: Limited information is available for patients with breast cancer (BC) and coronavirus disease 2019 (COVID-19), especially among underrepresented racial/ethnic populations. Methods: This is a COVID-19 and Cancer Consortium (CCC19) registry
Externí odkaz:
https://doaj.org/article/21b528e377ff490f938d7fabb4ca5424
Autor:
Tareq Salous, Nikhil A. Shukla, Sandra K. Althouse, Susan M. Perkins, Muhammad Furqan, Ticiana Leal, Anne M. Traynor, Lawrence E. Feldman, Nasser H. Hanna, Greg A. Durm
Publikováno v:
Cancer. 129:264-271
Immunotherapy using a checkpoint inhibitor (CPI) alone or in combination with chemotherapy is the standard of care for treatment-naive patients with advanced non-small cell lung cancer (NSCLC) without driver mutations for which targeted therapies hav
Publikováno v:
Seminars in Oncology. 49:198-205
The treatment of lung cancer has improved significantly in recent years however, lung cancer remains as a leading cause of cancer-related mortality worldwide. Lung cancer screening has been explored, over the past several decades, as a means of reduc
Autor:
Alicia Hulbert, James G. Herman, Malcolm V. Brock, Robert A. Winn, Enrico Benedetti, Ignacio Jusue-Torres, Tza-Huei Wang, Malek G. Massad, Lawrence E. Feldman, Mary Pasquinelli, Christian Ascoli, Ron C. Gaba, Odile David, Klara Valyi-Nagy, Nicole Gastala, Kyla Holmes, Tomoaki Ito, Chen Chen, Kristen Rodgers, Anastasia Kottorou, Cassandra Villani, Apurva Mallisetty, Julio Ricarte Filho, Bin Liu
Figure S4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1fe90dfe521f37d63182735dc89cfb75
https://doi.org/10.1158/1078-0432.22477200.v1
https://doi.org/10.1158/1078-0432.22477200.v1
Autor:
Alicia Hulbert, James G. Herman, Malcolm V. Brock, Robert A. Winn, Enrico Benedetti, Ignacio Jusue-Torres, Tza-Huei Wang, Malek G. Massad, Lawrence E. Feldman, Mary Pasquinelli, Christian Ascoli, Ron C. Gaba, Odile David, Klara Valyi-Nagy, Nicole Gastala, Kyla Holmes, Tomoaki Ito, Chen Chen, Kristen Rodgers, Anastasia Kottorou, Cassandra Villani, Apurva Mallisetty, Julio Ricarte Filho, Bin Liu
Gene Methylation Detection, Sensitivity, Specificity Using Detectable vs. Non-detectable cutoff in blacks
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24705d4d6a14d0383f0c0d3ad3d280ed
https://doi.org/10.1158/1078-0432.22477152.v1
https://doi.org/10.1158/1078-0432.22477152.v1
Autor:
Alicia Hulbert, James G. Herman, Malcolm V. Brock, Robert A. Winn, Enrico Benedetti, Ignacio Jusue-Torres, Tza-Huei Wang, Malek G. Massad, Lawrence E. Feldman, Mary Pasquinelli, Christian Ascoli, Ron C. Gaba, Odile David, Klara Valyi-Nagy, Nicole Gastala, Kyla Holmes, Tomoaki Ito, Chen Chen, Kristen Rodgers, Anastasia Kottorou, Cassandra Villani, Apurva Mallisetty, Julio Ricarte Filho, Bin Liu
Purpose:Low-dose CT screening can reduce lung cancer–related mortality. However, CT screening has an FDR of nearly 96%. We sought to assess whether urine samples can be a source for DNA methylation–based detection of non–small cell lung cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22112c19c2920970027a20ccc622f082
https://doi.org/10.1158/1078-0432.c.6529587.v1
https://doi.org/10.1158/1078-0432.c.6529587.v1
Autor:
Gowri Satyanarayana, Kyle T Enriquez, Tianyi Sun, Elizabeth J Klein, Maheen Abidi, Shailesh M Advani, Joy Awosika, Ziad Bakouny, Babar Bashir, Stephanie Berg, Marilia Bernardes, Pamela C Egan, Arielle Elkrief, Lawrence E Feldman, Christopher R Friese, Shipra Goel, Cyndi Gonzalez Gomez, Keith L Grant, Elizabeth A Griffiths, Shuchi Gulati, Shilpa Gupta, Clara Hwang, Jayanshu Jain, Chinmay Jani, Anna Kaltsas, Anup Kasi, Hina Khan, Natalie Knox, Vadim S Koshkin, Daniel H Kwon, Chris Labaki, Gary H Lyman, Rana R McKay, Christopher McNair, Gayathri Nagaraj, Elizabeth S Nakasone, Ryan Nguyen, Taylor K Nonato, Adam J Olszewski, Orestis A Panagiotou, Matthew Puc, Pedram Razavi, Elizabeth V Robilotti, Miriam Santos-Dutra, Andrew L Schmidt, Dimpy P Shah, Sumit A Shah, Kendra Vieira, Lisa B Weissmann, Trisha M Wise-Draper, Ulysses Wu, Julie Tsu-Yu Wu, Toni K Choueiri, Sanjay Mishra, Jeremy L Warner, Benjamin French, Dimitrios Farmakiotis
Publikováno v:
Open forum infectious diseases, vol 9, iss 3
Background The frequency of coinfections and their association with outcomes have not been adequately studied among patients with cancer and coronavirus disease 2019 (COVID-19), a high-risk group for coinfection. Methods We included adult (≥18 year